- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1 IPO registration
- 3.1.1 Exhibit 3.1.1
- 3.1.2 Exhibit 3.1.2
- 3.2.1 Exhibit 3.2.1
- 3.2.2 Exhibit 3.2.2
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6.1 Exhibit 10.6.1
- 10.6.2 Exhibit 10.6.2
- 10.6.3 Exhibit 10.6.3
- 10.7.1 Exhibit 10.7.1
- 10.7.2 Exhibit 10.7.2
- 10.7.3 Exhibit 10.7.3
- 10.7.4 Exhibit 10.7.4
- 10.8.1 Exhibit 10.8.1
- 10.8.2 Exhibit 10.8.2
- 10.8.3 Exhibit 10.8.3
- 10.8.4 Exhibit 10.8.4
- 10.9.1 Exhibit 10.9.1
- 10.9.2 Exhibit 10.9.2
- 10.9.3 Exhibit 10.9.3
- 10.10.1 Exhibit 10.10.1
- 10.10.2 Exhibit 10.10.2
- 10.10.3 Exhibit 10.10.3
- 10.11 Exhibit 10.11
- 23.1 Exhibit 23.1
Exhibit 23.1 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of NephroGenex, Inc. on Form S-1 to be filed on or about December 23, 2013of our report dated December 20, 2013, on our audits of the financial statements as of December 31, 2012 and 2011 and foreach of the years in the two-year period ended December 31, 2012 and the cumulative period from May 25, 2004 (inception) to December 31, 2012. Our report includes explanatory paragraphs about the existence of substantial doubt concerning the Company’s ability to continue as a going concern and the restatement of certain financial statement accounts.We also consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form S-1.
/s/ EisnerAmper LLP
Jenkintown, Pennsylvania
December 20, 2013